EMRNEUTRAL

Return on Equity (ROE)

12.3%

Updated 176h ago

Sector Performance

45th percentile

EMR

12.3%

Sector Median

13.8%

Sector Avg

31.4%

📊

Deep Analysis

Return on Equity (ROE) shows how efficiently a company uses shareholder money to generate profit – a 12.3% ROE means EMR earns $0.123 for every dollar of equity.

This sits just below the sector median of 13.5%, placing EMR in the 45th percentile among peers. The year-over-year change is not available, and the quarter-over-quarter change is also not available, so no trend direction can be determined from the single reported value of 12.3%. Because the ROE is slightly below the sector median and there is no trend data to indicate improvement or decline, the metric implies a neutral risk-opportunity profile with no clear advantage or warning. This metric directly supports the overall NEUTRAL verdict, as it neither contradicts nor strengthens a bullish or bearish case.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about EMR?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

Who are EMR's closest peers by Return on Equity (ROE)?

The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.